Free
Education  |   February 1994
Long-term Intrathecal Morphine and Bupivacaine in Patients with Refractory Cancer Pain Results from a Morphine, Bupivacaine Dose Regimen of 0.5:4.75 mg/ml
Author Affiliations & Notes
  • Magnus Sjöberg, M.D.
    *
  • Petre Nitescu, M.D.
  • Lennart Appelgren, M.D., Ph.D.
  • Ioan Curelaru, M.D., Ph.D.
  • * Research Fellow and Resident in Anesthesiology.
  • Staff Anesthesiologist, Senior Consultant.
  • Associate Professor of Clinical Anesthesiology.
Article Information
Education
Education   |   February 1994
Long-term Intrathecal Morphine and Bupivacaine in Patients with Refractory Cancer Pain Results from a Morphine, Bupivacaine Dose Regimen of 0.5:4.75 mg/ml
Anesthesiology 2 1994, Vol.80, 284-297. doi:
Anesthesiology 2 1994, Vol.80, 284-297. doi:
First Page Preview
First page PDF preview
First page PDF preview ×
View Large